Serine Protein Kinase Market
Global Serine Protein Kinase Market Size, Share and Trends Analysis Report, By Type (AZD-0156, AZD-1390, KU-55933, M-3541, and Others), By Application (Cancer, Adenocarcinoma, and Others), Forecast (2022-2028)
The global serine protein kinase market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). A serine protein kinase is a kinase enzyme that phosphorylates that OH group of serine or threonine. It regulates a variety of cell functions such as cell cycle, cell proliferation, apoptosis, and cell differentiation. Protein kinase can regulate the whole process of neoplasia, including proliferation, invasion, angiogenesis, and metastasis. Inhibiting the phosphorylation process of the protein kinase can treat many types of cancers. To inhibit the process of phosphorylation amino acid, kinases mainly act on serine and threonine kinase. Some dual-specificity kinases are acting on three amino acid residues, including serine, threonine, or tyrosine kinase. Several protein kinases also phosphorylate other amino acids.
The major factors that are contributing the growth of the market include increasing prevalence of cancer globally. As per the WHO estimates in 2020, there were 10 million deaths due to cancer. Moreover, 2.26 million breast cancer, 2.21 million lung cancer, 1.93 million colon and rectum cancer and 1.41 million prostate cancer new cases were found. As Serine threonine kinases (STKs) inhibitors are active against ovarian cancer and tumors with specific molecular alterations, they are highly adapted by the healthcare sector which in market growth.
Impact of COVID-19 on Global Serine Protein Kinase Market
The COVID-19 has affected the healthcare systems globally and also has a significant impact on the market. The worldwide lockdowns may have resulted in lowering the sales of the market in the current situation. However, the protein kinase inhibitor market is expected to grow in the upcoming years due to which various factors as mentioned above.
Segmental Outlook
The global serine protein market is segmented based on the type and based on application. Based on the type the market is sub-segmented into AZD-0156, AZD-1390, KU-55933, M-3541, and others. Based on the application the market is sub-segmented into cancer, adenocarcinoma, and others. The above-mentioned segments can be customized as per requirements.
Global Serine Protein Kinase by Application, 2022 (%)
The cancer segment is anticipated to hold a prominent share in the Global Serine Protein Market
Cancer has a major impact on society across the world. As it is one of the leading causes of death across the globe and is more prevalent in developed economies across the globe. The prevalence of cancer is driving the demand for serine protein owing to its role in the initiation and treatment of progression of cancers. Awareness about cancer diagnosis and treatment is being spread across the globe. Government bodies are also taking initiatives to provide access to health care to the public. For instance, in November 2020, Merck KGaA entered into a definitive agreement to acquire Velosbio Inc, a privately held clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1). Such strategies adopted by the key players will boost the growth of the market.
Regional Outlook
The global serine protein kinase tablets market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, Rest of Europe), Asia Pacific (India, China, Japan, South Korea, Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa).
Global Serine Protein Kinase Market by Region, 2022-2028
The Asia-Pacific region is estimated to be the fastest growing in the Global Serine Protein Market
Asia-Pacific region is expected to observe a substantial growth in the protein serine kinase market due to the availability of funds for research and development of new cancer treatment drugs and therapies. For instance, as per the Cancer Research Institute, in 2021, around $28.5 million is awarded to researchers for cancer R&D. On the other hand, South Asia is anticipated to experience the fastest growth in the serine protein kinase market due to the increase in the prevalence of cancer disease. As per the American Cancer Society, in 2018, 8.2 million new cancer cases and 5.2 million cancer deaths were estimated in the region, corresponding to around half of the cancer burden worldwide. China alone accounts for 52% of new cancer cases (4.3 million) and 55% of cancer deaths (2.9 million) in the region. Overall, cancers of the lung (1,166,200 new cases, 15% of all cases), colorectum (914,200, 11%) and female breast (845,400, 10%) are the most common cancers. Lung cancer was the leading cause of death (1,013,100 deaths, 21% of all deaths), followed by stomach (560,500, 11%) and liver cancer (554,000, 11%). The increasing prevalence is further projected to create scope for the market growth.
Market Players
The major companies serving the global serine protein kinase market include Novartis AG, Pfizer Inc, Eli Lilly and Co, Bayer AG, AstraZeneca plc, Merck KGaA, and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launches, mergers, and acquisitions, collaborations with the government, and new drug commercialization to stay competitive in the market.
The report covers
- Market value data analysis of 2022 and forecast to 2028
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global protein kinase market.
- Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Serine Protein Kinase Market
1.1. Recovery Scenario of Global Serine Protein Kinase Market
1.2. Research Methods and Tools
1.3. Market Breakdown
1.3.1. By Segments
1.3.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Eli Lilly and Co
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. AstraZeneca plc
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Merck KGaA
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Bayer AG
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Pfizer Inc
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
Global Serine Protein Kinase Market by Type
4.1.1. AZD-0156
4.1.2. AZD-1390
4.1.3. KU-55933
4.1.4. M-3541
4.1.5. Others
Global Serine Protein Kinase Market by Application
4.1.6 Cancer
4.1.7 Adenocarcinoma
4.1.8 Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1 Latin America
5.4.2 Middle East and Africa
6. Company Profiles
6.1. Bristol-Myers Squibb Company
6.2. CanBas Co Ltd
6.3. Cascadian Therapeutics Inc
6.4. CytRx Corporation
6.5. Eisai Co Ltd
6.6. F. Hoffmann-La Roche Ltd
6.7. Genentech Inc
6.8. InteRNA Technologies B.V.
6.9. Johnson & Johnson Pvt Ltd
6.10. Novartis AG
6.11. Osi Pharmaceutical Inc
6.12. ProNAi Therapeutics Inc
6.13. Sareum Holdings Plc
6.14. Shuttle Pharmaceutical LLC
6.15. Vernalis Plc
1. GLOBAL SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL AZD-0156 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
3. GLOBAL AZD-1390 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
4. GLOBAL KU-55933 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
5. GLOBAL M-3541 SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
6. GLOBAL OTHER SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
7. GLOBAL SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
8. GLOBAL SERINE PROTEIN KINASE IN CANCER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
9. GLOBAL SERINE PROTEIN KINASE IN ADENOCARCINOMA MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
10. GLOBAL SERINE PROTEIN KINASE IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. GLOBAL SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. NORTH AMERICAN SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
14. EUROPEAN SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. EUROPEAN SERINE PROTEIN KINASEMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC SERINE PROTEIN KINASE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
18. REST OF THE WORLD SERINE PROTEIN KINASEMARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. REST OF THE WORLD SERINE PROTEIN KINASEMARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL SERINE PROTEIN KINASE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 (%)
4. GLOBAL SERINE PROTEIN KINASE MARKET SHARE BY TYPE, 2021 VS 2028(%)
5. GLOBAL AZD-0156 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
6. GLOBAL AZD-1390 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
7. GLOBALKU-55933 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
8. GLOBAL M-3541 SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
9. GLOBAL OTHERS SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
10. GLOBAL SERINE PROTEIN KINASE MARKET BY APPLICATION, 2021 VS 2028(%)
11. GLOBAL CANCER SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
12. GLOBAL ADENOCARCINOMA SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
13. GLOBAL OTHERS SERINE PROTEIN KINASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028(%)
14. GLOBAL SERINE PROTEIN KINASE MARKET BY GEOGRAPHY, 2021 VS 2028(%)
15. US GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
17. UK GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
19. GERMANY GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
24. CHINA GLOBAL SERINE PROTEIN KINASEMARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN GLOBAL SERINE PROTEIN KINASE MARKET, 2021-2028 ($ MILLION)
26. SOUTH KOREA GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF ASIA-PACIFIC GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD GLOBAL SERINE PROTEIN KINASE MARKET SIZE, 2021-2028 ($ MILLION)
